Lv1
10 积分 2024-11-03 加入
723P A phase II study of cadonilimab plus chemotherapy in persistent recurrent/ metastatic cervical cancer patients who failed previous immuno/chemotherapy
3天前
求助中
The efficacy and safety of cadonilimab after first anti-PD-1 failure in the treatment of recurrent endometrial and cervical carcinoma: A retrospective, real-world study
3天前
已完结
Mechanisms and strategies to overcome immunotherapy resistance in hepatobiliary malignancies
3天前
已完结
How I Treat Non–Small Cell Lung Cancer Refractory to Immunotherapy
4天前
已完结
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
4天前
已完结
Treatment patterns and prognosis of patients with clear cell adenocarcinoma of the cervix: A population-based cohort study
9天前
已完结
皖公网安备34019202002308
